7 States Sue Purdue Pharma Over Opioid Crisis
The state of New York said Wednesday it's suing Purdue Pharma for "reckless disregard" in selling narcotic painkillers that contribute to the opioid crisis.
New York joins six other states in suing Purdue -- Florida, Nevada, North Carolina, North Dakota, Tennessee and Texas -- for its manufacture of the drug OxyContin. The state attorneys general said the drug maker uses misleading marketing tactics.
New York Attorney General Barbara Underwood said New York is committed to holding opioid manufacturers and distributors accountable for the damage they've wrought on New York's towns, communities, and families.
"We are preparing a lawsuit against Purdue Pharma for its alleged deception and reckless disregard for the health and wellbeing of New Yorkers, Underwood said in a statement. "It is clear to us that Purdue profited by deliberately exploiting New Yorkers' addictions, and by pushing healthcare providers to increase patients' use and dependence on these potentially fatal drugs."
New York Governor Andrew Cuomo said the state "will not sit idly by as big corporations fuel the opioid epidemic and ignore the consequences of their actions."
"Too many innocent lives have been lost and too many families destroyed," he said.
New York and other states announced a nationwide investigation last summer into major opioid manufacturers and distributors.
Texas Attorney General Ken Paxton said Tuesday Purdue sold its drugs knowing they were "potentially dangerous" and its use has "a high likelihood" of addiction.
"As Purdue got rich from sales of its opioids, Texans and others across the nation were swept up in a public health crisis," Paxton said.
Purdue said it is also concerned with the crisis.
"This is our fight too," a statement on its website said.
Earlier this year, Purdue announced it would no longer market OxyContin directly to physicians.
The company said patients' needs and safety is what led to research and development of medications to help patients.
"It's what has spurred us to redouble our efforts in the fight against the prescription and illicit opioid abuse crisis. It's why we're taking action," Purdue said.
The drug maker said some blame should fall on doctors, who should check state monitoring databases before writing a prescription for narcotics to identify those with drug-seeking behaviors.
President Donald Trump has said opioid addiction "is a serious problem the likes of which we have never had" and declared a national health emergency.



E. Rock Fire Dept. awarded $20K grant
Foot Healers in St. Louis settles Medicare fraud charges over toenail clippings
Advisor News
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
- More investors will seek comprehensive financial planning
- Midlife planning for women: why it matters and how advisors should adapt
- Tax anxiety is real, although few have a plan to address it
More Advisor NewsAnnuity News
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
- Corebridge Financial, Equitable Holdings post Q1 earnings as merger looms
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
More Annuity NewsHealth/Employee Benefits News
- Prime Healthcare hospitals will stay in-network with Blue Cross and Blue Shield of Illinois, after months of uncertainty
- LEADING HEALTH ORGANIZATIONS URGE NC LAWMAKERS TO RECONSIDER IMPLEMENTATION OF MEDICAID CUTS
- PCA PAPER WORKERS IN MINNESOTA RATIFY STRONG AGREEMENT WITH MAJOR WAGE GAINS, PROTECTED HEALTH INSURANCE
- Humana is cutting Medicare benefits for hundreds of thousands in GA. Here's who will be affected
- CMS Releases Proposed Rule To Improve Prior Authorization Processes
More Health/Employee Benefits NewsLife Insurance News
- AM Best Assigns Credit Ratings to Tokio Marine Newa Insurance Co., Ltd.
- Earnings roundup: Prudential works to save ‘unique’ Japanese market
- How life insurance became a living-benefits strategy
- Financial Focus : Keep your beneficiary choices up to date
- Equitable-Corebridge merger casts shadow over life insurance earnings
More Life Insurance News